SCGB3A2 and colorectal neoplasm: Immunohistochemistry showed that these colorectal tumor nodules expressed CASP4 in lung metastases, which was enhanced by SCGB3A2 administration and correlated with the inhibition of tumors (Fig. 4D for HCT116, data not shown).